Dr Reddys Laboratories RDY
NYSE RDY
$12.25 +0.01 (+0.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dr Reddys Laboratories (RDY) Investment Income (2017 - 2018)

Updated

Dr Reddys Laboratories (RDY) recorded Investment Income of -$3.91 million in the quarter ended Dec 31, 2018, compared with -$12.45 million a year earlier.

Analysis

Dr Reddys Laboratories (RDY) Investment Income (2017 - 2018) Analysis & Trends

On a TTM basis, Dr Reddys Laboratories' Investment Income came in at -$19.58 million as of Dec 31, 2018.

  • Quarterly Investment Income has ranged from -$12.45 million in the quarter ended Dec 31, 2017 to -$1.37 million in the quarter ended Sep 30, 2017 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inv. Income (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Dr Reddys Laboratories 10.22 Bn 9.41 Bn 396.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -3.91 Mn
Sep 30, 2018 -1.61 Mn
Jun 30, 2018 -1.61 Mn
Dec 31, 2017 -12.45 Mn
Sep 30, 2017 -1.37 Mn
API Access

Dr Reddys Laboratories Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=investment-income&ticker=RDY&period=max&api_key=YOUR_API_KEY